
Welcome to this overview of eosinophilic granulomatosis with polyangiitis with Michael Wechsler, MD. In this activity, Dr. Wechsler reviews the pathogenesis, diagnosis, prognosis, and treatment of EGPA. This presentation will help you recognize EGPA and differentiate it from other diagnoses and other small-vessel vasculitides, and develop treatment plans based on the patient’s prognosis and response to first-line treatments.
Want to learn more?
- Visit Part 2 of this two-part educational series to learn about diagnosis, prognosis, and treatment of EGPA.
- Hear from a patient with EGPA https://youtu.be/8Q0x7zMyqr8?t=14
Course Credit:
1.00 AANP Contact Hour
1.00 AMA PRA Category 1 CreditTM
Dates:
Opens: 2020-07-31
Closes: 2021-07-30
Target Audience:
This activity was developed for allergist/immunologists, rheumatologists, pulmonologists, hematologists, dermatologists, cardiologists, EENT specialists and other clinicians involved in the care of patients with EGPA.
This educational activity is supported by an educational grant from GlaxoSmithKline.
-
Michael Wechsler, MD
Professor of Medicine
Director, NJH Cohen Family Asthma Institute
Department of Medicine
National Jewish Health
Denver, Colorado
Learning Objectives
- Discuss the clinical signs and symptoms that support a diagnosis of EGPA
- Describe the clinical progression of EGPA
- Classify patients’ risk based on disease activity and the presence of ANCA
- Select an appropriate therapy for EGPA based on patient’s disease activity and characteristics
Faculty Disclosures
Michael Wechsler, MD
Consultant
- AstraZeneca – clinical area: Asthma/EGPA
- Equillium – clinical area: Asthma
- Genentech – clinical area: Asthma
- Genzyme – clinical area: Asthma
- GlaxoSmithKline – clinical area: Asthma/EGPA
- Regeneron – clinical area: Asthma
- Restorbio – clinical area: Asthma
- Sanofi – clinical area: Asthma
- Teva – clinical area: Asthma
Speakers bureau
- AstraZeneca – clinical area: Asthma/EGPA
- GlaxoSmithKline – clinical area: Asthma/EGPA
- Sanofi – clinical area: Asthma
Accreditation and Certification
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This program is designated for up to 1.00 contact hour. Program ID# 5825-EM1.
Additional Content Planners
Juan Cardet, MD (Peer Reviewer)No significant relationships to disclose.
Chris Fischer, MSc (Medical Writer)
No significant relationships to disclose.
Heather M. Jimenez, FNP-C (Nurse Reviewer)
No significant relationships to disclose.
Annenberg Center for Health Sciences
All staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.